Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

27.28 +0.42 (+1.56%)

Delayed Quote Updated: 4:00 PM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

34 35 Next >

Down 34%, Should You Buy the Dip on Viking Therapeutics? ↗

September 05, 2025

Viking aims to enter the billion-dollar weight loss drug market.

Via The Motley Fool

Prediction: These 2 Biotech Stocks Could Double in the Next 5 Years ↗

September 04, 2025

Both companies have made significant progress in recent years.

Via The Motley Fool

The Problem With Weight Loss Stocks ↗

September 03, 2025

There are new ways to tackle weight loss, but the stocks leading the way are lagging.

Via The Motley Fool

Topics Economy

2 Beaten-Down Stocks That Could Rocket 142% to 222% Higher, According to Wall Street Analysts ↗

August 29, 2025

Investment bank analysts up and down Wall Street are pounding the table on these stocks.

Via The Motley Fool

Viking Short Interest Hits 5-Year High After Weight-Loss Drug Stumble, But Retail Clings To Bullish Mood For Now ↗

August 24, 2025

Via Stocktwits

Wall Street Defends Viking As Weight Loss Pill Trial Results Trigger Stock Rout; Retail Calls Selloff ‘Unjustified’ ↗

August 19, 2025

Via Stocktwits

Intel, Palantir, Home Depot, Viking, Nio: Stocks Making The Biggest Moves Today ↗

August 19, 2025

Via Stocktwits

Why Viking Therapeutics Stock Popped Nearly 4% Today ↗

August 28, 2025

The company's obesity drug could have more potential than originally believed.

Via The Motley Fool

Billionaire Stanley Druckenmiller Just Bought the Dip on This Beaten-Down GLP-1 Stock (Hint: It's Not Eli Lilly or Novo Nordisk) ↗

August 27, 2025

Druckenmiller's Duquesne Family Office just scooped up a popular weight-loss stock.

Via The Motley Fool

Topics Economy World Trade

Why Is Viking Therapeutics Stock Crashing, and Is It a Buying Opportunity? ↗

August 27, 2025

The market for weight loss treatments is growing significantly and is forecast to continue increasing for several years.

Via The Motley Fool

Eli Lilly Scores Another Weight-Loss Win; Viking, Novo Stocks Slump ↗

August 26, 2025

Eli Lilly said Tuesday it will soon ask global regulators to approve its weight-loss pill following a third successful test.

Via Investor's Business Daily

Viking Therapeutics: What's Next? ↗

August 26, 2025

Viking's 40% crash over fixable dosing issues ignores its best-in-class 12.2% oral weight loss and Phase 3 momentum.

Via The Motley Fool

2 Biotech Stocks That Could Soar 21% and 245% According to Wall Street's Top Analysts ↗

August 24, 2025

These companies aren't performing as badly as their stock-market performances this year suggest.

Via The Motley Fool

Benzinga Bulls And Bears: Sunrun, Newegg, Walmart — And Powell Offers Rate Cut Hope ↗

August 23, 2025

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 22, 2025

Via Benzinga

Here's Why Shares in Viking Therapeutics Crashed This Week ↗

August 22, 2025

The phase 2 trial results for its key drug didn't pan out quite as planned.

Via The Motley Fool

Market Brief: After Viking Therapeutics’ Results, Is Entera Bio the Oral Platform Play to Watch? (NASDAQ: ENTX)

August 22, 2025

Via AB Newswire

Is Beaten-Down Viking Therapeutics Stock a Buy on the Dip? ↗

August 21, 2025

A disappointing result for its oral obesity candidate hammered the stock price.

Via The Motley Fool

Here's Why Viking Therapeutics Bounced Back Today ↗

August 20, 2025

Viking's key drug demonstrated excellent body weight reduction data in a phase 2 trial, but its safety and tolerability data were disappointing.

Via The Motley Fool

Under Pressure: Palantir and Viking Therapeutics Face Investor Scrutiny

August 20, 2025

The financial markets are a dynamic arena where fortunes can shift rapidly, and the past week has seen two prominent companies, Palantir Technologies Inc. (NYSE: PLTR) and Viking Therapeutics (NASDAQ:...

Via MarketMinute

Topics Artificial Intelligence

Viking's 42% Plunge Splits Experts—A '$129 Strong Buy' Or 'Clearly Inferior' Drug? ↗

August 20, 2025

Viking (VKTX) stock plunged 42% after its obesity pill trial. Experts are split: some call it a $129 Strong Buy, others say it's inferior.

Via Benzinga

Viking Therapeutics Plummets as Oral Obesity Drug Trial Raises Tolerability Concerns

August 19, 2025

San Diego, CA – Viking Therapeutics (NASDAQ: VKTX) experienced a dramatic stock decline today following the release of disappointing clinical trial results for its highly anticipated oral tablet...

Via MarketMinute

Palantir, AMD, Oracle, Viking And Nvidia: Why These 5 Stocks Are On Investors' Radars Today ↗

August 19, 2025

U.S. stock indices closed mixed on Tuesday, with the Dow Jones Industrial Average edging up 0.02% to 44,922.27.

Via Benzinga

Topics Stocks

Which stocks are experiencing notable movement on Tuesday? ↗

August 19, 2025

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.

Via Chartmill

Viking Obesity Pill Faces Steep Climb Against Lilly's Tirzepatide, Analyst Calls Downtrend Reaction 'Extreme' ↗

August 19, 2025

Viking shares fell on Phase 2 obesity pill data as tolerability issues surfaced, but William Blair says the stock's sell-off is excessive.

Via Benzinga

Tech Stocks Drop, Palantir Plunges Over 8%: What's Moving Markets Tuesday? ↗

August 19, 2025

Tech stocks pulled back on Tuesday as the absence of fresh bullish catalysts prompted investors to take profits after the recent months-long rally.

Via Benzinga

Nasdaq Down Over 300 Points; Medtronic Posts Upbeat Earnings ↗

August 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 19, 2025

Via Benzinga

These stocks are moving in today's session ↗

August 19, 2025

Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.

Via Chartmill

Why Novo Nordisk Stock Popped Today ↗

August 19, 2025

For a cheap GLP-1 weight loss stock like Novo Nordisk, almost any news can help the stock pop.

Via The Motley Fool

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

34 35 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.